The concordance rate of the CDX2 expression status was 100%, and the association between the CDX2 expression status of metastatic lesions and that of the primary CRC lesions was statistically significant (P = 0.041), indicating that the metastatic process did not affect the CDX2 expression status in CRCs. This evidence concerns the gene CDX2 and colorectal carcinoma.